Japan records surprise trade deficit in July as exports weaken further
ST. PAUL, Minn. - H.B. Fuller Company (NYSE:FUL) announced Thursday that its Board of Directors has declared a regular quarterly cash dividend of $0.2350 per share of common stock.
The dividend will be payable on August 14, 2025, to shareholders of record at the close of business on July 31, 2025, according to a company press release.
This payment marks the continuation of H.B. Fuller’s 57-year track record of consecutive quarterly cash dividend distributions to its shareholders.
H.B. Fuller, which describes itself as the largest pureplay adhesives company globally, reported revenue of $3.6 billion in 2024. The company manufactures functional coatings, adhesives and sealants for various industries.
Founded in 1887, H.B. Fuller employs approximately 7,500 people worldwide and operates across more than 30 market segments in over 140 countries.
In other recent news, H.B. Fuller reported its second-quarter earnings for 2025, revealing an adjusted earnings per share (EPS) of $1.18, surpassing the forecasted $1.08, which marked a 9.26% surprise. However, the company slightly missed revenue expectations, reporting $898 million against the forecasted $900.07 million. Despite this minor shortfall in revenue, the company’s stock experienced a significant surge following the earnings announcement. H.B. Fuller’s performance was bolstered by a strong showing in flexible packaging and medical adhesives, alongside ongoing cost savings and operational efficiencies. The company also highlighted a 5% year-over-year increase in adjusted EPS and a 5% rise in adjusted EBITDA to $166 million. Looking forward, H.B. Fuller projects its net revenue for the full year 2025 to decline by 2-3% year-over-year, with organic revenue expected to be flat to up 2%. The company anticipates adjusted EBITDA growth of 4-6%, reaching $615-$630 million, and adjusted EPS between $4.10 and $4.30. Additionally, H.B. Fuller continues to focus on innovative products in packaging automation and medical adhesives, contributing to its strategic growth.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.